These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 19110648)

  • 1. Life support of artificial liver: development of a bioartificial liver to treat liver failure.
    Kobayashi N
    J Hepatobiliary Pancreat Surg; 2009; 16(2):113-7. PubMed ID: 19110648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid bioartificial liver: establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use.
    Kobayashi N; Okitsu T; Nakaji S; Tanaka N
    J Artif Organs; 2003; 6(4):236-44. PubMed ID: 14691665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioartificial liver systems: current status and future perspective.
    Park JK; Lee DH
    J Biosci Bioeng; 2005 Apr; 99(4):311-9. PubMed ID: 16233796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acetaminophen-induced acute liver failure in the mouse with conditionally immortalized human hepatocytes.
    Nguyen TH; Mai G; Villiger P; Oberholzer J; Salmon P; Morel P; Bühler L; Trono D
    J Hepatol; 2005 Dec; 43(6):1031-7. PubMed ID: 16169114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes.
    Soto-Gutiérrez A; Kobayashi N; Rivas-Carrillo JD; Navarro-Alvarez N; Zhao D; Okitsu T; Noguchi H; Basma H; Tabata Y; Chen Y; Tanaka K; Narushima M; Miki A; Ueda T; Jun HS; Yoon JW; Lebkowski J; Tanaka N; Fox IJ
    Nat Biotechnol; 2006 Nov; 24(11):1412-9. PubMed ID: 17086173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of liver failure using tissue engineering techniques].
    Pokrywczyńska M; Drewa T
    Pol Merkur Lekarski; 2007 Jul; 23(133):66-9. PubMed ID: 18051833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bigger may not be better when it comes to hepatocytes.
    Strom SC; Cai H; Ellis E; Mitamura K; Miki T
    Liver Transpl; 2006 Jan; 12(1):16-8. PubMed ID: 16382453
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for Galalpha(1-3)Gal expression on primary porcine hepatocytes: implications for bioartificial liver systems.
    van de Kerkhove MP; Germans MR; Deurholt T; Hoekstra R; Joziasse DH; van Wijk AC; van Gulik TM; Chamuleau RA; Roos A
    J Hepatol; 2005 Apr; 42(4):541-7. PubMed ID: 15763340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic tissue engineering for adjunct and temporary liver support: critical technologies.
    Chan C; Berthiaume F; Nath BD; Tilles AW; Toner M; Yarmush ML
    Liver Transpl; 2004 Nov; 10(11):1331-42. PubMed ID: 15497161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioartificial liver support. Review and personal experience.
    Ambrosino G; D'Amico DF
    Minerva Chir; 2003 Oct; 58(5):649-56. PubMed ID: 14603145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of hepatocytes derived from early ES cells and treatment of surgically induced liver failure rats by transplantation.
    Tabei I; Hashimoto H; Ishiwata I; Tachibana T; Akahori M; Ohi S; Kubo H; Satou K; Yamazaki Y; Yanaga K; Ishikawa H
    Transplant Proc; 2005; 37(1):262-4. PubMed ID: 15808614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical issues in bioartificial liver development.
    Tilles AW; Berthiaume F; Yarmush ML; Toner M
    Technol Health Care; 2002; 10(3-4):177-86. PubMed ID: 12118141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of human hepatocytes from livers rejected for liver transplantation on a national basis: results of a 2-year experience.
    Baccarani U; Sanna A; Cariani A; Sainz-Barriga M; Adani GL; Zambito AM; Piccolo G; Risaliti A; Nanni-Costa A; Ridolfi L; Scalamogna M; Bresadola F; Donini A
    Liver Transpl; 2003 May; 9(5):506-12. PubMed ID: 12740795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioartificial liver: its pros and cons.
    Chamuleau RA; Poyck PP; van de Kerkhove MP
    Ther Apher Dial; 2006 Apr; 10(2):168-74. PubMed ID: 16684219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Potential of cell transplantation as an alternative to liver transplantation].
    Li S; Huang X; Chen H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Apr; 28(2):405-9. PubMed ID: 21604511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal tissue engineered liver-assist devices.
    Tzanakakis ES; Hess DJ; Sielaff TD; Hu WS
    Annu Rev Biomed Eng; 2000; 2():607-32. PubMed ID: 11701525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatic tissue engineering].
    Fiegel HC; Kneser U; Kluth D; Rolle U
    Handchir Mikrochir Plast Chir; 2010 Dec; 42(6):337-41. PubMed ID: 20405372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bioartificial liver--state of the art.
    Strain AJ; Neuberger JM
    Science; 2002 Feb; 295(5557):1005-9. PubMed ID: 11834813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in bioreactors of bioartificial livers.
    Yu CB; Pan XP; Li LJ
    Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):134-40. PubMed ID: 19357025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-based therapy for liver diseases.
    Di Campli C; Nestola M; Piscaglia AC; Santoliquido A; Gasbarrini G; Pola P; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2003; 7(2):41-4. PubMed ID: 12911118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.